Marie-Anne Rameix Welti

University of Paris-Saclay - Laboratoire de Microbiologie

55 Avenue de Paris

Versailles, 78000

France

SCHOLARLY PAPERS

3

DOWNLOADS

285

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

Effectiveness of Covid-19 Vaccines Administered in the 2023 Autumnal Campaigns in Europe: Results from the Vebis Primary Care Test-Negative Design Study, September 2023–January 2024

Number of pages: 27 Posted: 01 May 2024
Epiconcept, National Institute of Health Doutor Ricardo Jorge, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, Robert Koch Institute, Health Service Executive, Semmelweis University, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Croatian Institute of Public Health, Public Health Agency of Sweden, Romanian Institute of Science and Technology - National Institute of Research and Development for Microbiology and Immunology „Cantacuzino”, Carlos III Health Institute, Robert Koch Institute, University College Dublin (UCD), Semmelweis University, University of Paris-Saclay - Laboratoire de Microbiologie, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Instituto de Salud Pública y Laboral de Navarra, NIVEL (Netherlands Institute for Health Services Research), Croatian Institute of Public Health, Public Health Agency of Sweden, National Institute for Public Health and the Environment (RIVM), National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, Consejería de Sanidad, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 133 (442,372)
Citation 2

Abstract:

Loading...

COVID-19, vaccine effectiveness, multicentre study, test-negative design, Europe, SARS-CoV-2

2.

Effectiveness of XBB.1.5 Vaccines against Symptomatic SARS-CoV-2 Infection in Older Adults during the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Number of pages: 17 Posted: 11 Jul 2024
Epiconcept - Epidemiology Department, Epiconcept, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Carlos III Institute of Health, Health Protection Surveillance Centre (HPSC), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, NIVEL (Netherlands Institute for Health Services Research), National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Epiconcept, Consejería de Sanidad - Dirección General de Salud Pública, University College Dublin (UCD), University of Paris-Saclay - Laboratoire de Microbiologie, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute of Health Doutor Ricardo Jorge, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, National Institute for Public Health and the Environment (RIVM), National Institute of Health Doutor Ricardo Jorge, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 82 (618,692)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Vaccine effectiveness, Primary care, Case-control study, Test-negative design, Multi-country study

3.

Evaluation of 31 Commercial SARS-CoV-2 Serology Assays

Number of pages: 30 Posted: 22 Oct 2020
Hôpital Paul-Brousse - Service de Virologie, University of Paris - Hôpital Saint-Louis, University Paris Saclay - Service de Virologie, Université Paris Nord - Laboratoire de Microbiologie Clinique, Université Paris Nord - Laboratoire de Microbiologie Clinique, Université Paris Nord - Laboratoire de Microbiologie Clinique, University of Paris-Saclay - Laboratoire de Microbiologie, University of Paris-Saclay - Laboratoire de Microbiologie, University of Paris-Saclay - Laboratoire de Microbiologie, Department of Microbiology, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris(AP-HP), Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, Université de Paris - Laboratoire de Virologie, Université de Paris - Laboratoire de Virologie, Université de Paris - Laboratoire de Virologie, Université de Paris - Laboratoire de Virologie, Université de Paris - Service de Virologie, Equipe Mobile d’Infectiologie, AP-HP, Hôpital Cochin, Université de Paris - Service de Virologie, Sorbonne University - Laboratoire de virologie, Sorbonne University - Laboratoire de virologie, Sorbonne University - Laboratoire de virologie, Sorbonne University - Laboratoire de virologie, University of Paris - Reference Laboratory for Cytomegalovirus Infections, Université de Paris - APHP Laboratoire de Microbiologie clinique, Laboratoire De Virologie, AP-HP, Hôpital Necker-Enfants Malades, Universite Paris Descartes, AP-HP, CHU Necker Enfants Malades,EA 7327 Université Paris Descartes, Université de Paris - Service de Microbiologie, Université de Paris - Service de Microbiologie, Université de Paris - Département d'Immunologie, Université de Paris - Département d'Immunologie, Sorbonne University - Département de Virologie, Sorbonne University - Département de Virologie, Sorbonne University - Département de Virologie, University of Paris - Hôpital Saint-Louis, Université Paris VII Denis Diderot - INSERM U941, University of Paris - Hôpital Saint-Louis, University Paris Saclay - Service de Virologie, Hôpital Bicêtre - Service de Bactériologie-hygiène, Hôpital Bicêtre - Service de Bactériologie-hygiène, Médecins Sans Frontières - Mini-Lab project, University Paris Saclay - Service de Virologie, Sorbonne Université - Laboratoire de virologie and Université de Paris - Laboratoire de Virologie
Downloads 70 (673,979)

Abstract:

Loading...

Serology, SARS-CoV-2, COVID-19